Jane Street’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,822
| Closed | -$404K | – | 10851 |
|
|
2022
Q3 | $404K | Sell |
7,822
-65,074
| -89% | -$2.69M | ﹤0.01% | 7079 |
|
|
2022
Q2 | $1.81M | Sell |
72,896
-41,935
| -37% | -$924K | ﹤0.01% | 4357 |
|
|
2022
Q1 | $2.88M | Buy |
114,831
+26,385
| +30% | +$741K | ﹤0.01% | 4036 |
|
|
2021
Q4 | $3.22M | Buy |
88,446
+34,529
| +64% | +$1.21M | ﹤0.01% | 3573 |
|
|
2021
Q3 | $921K | Sell |
53,917
-260,862
| -83% | -$4.06M | ﹤0.01% | 6076 |
|
|
2021
Q2 | $4.21M | Buy |
314,779
+298,996
| +1,894% | +$7.37M | ﹤0.01% | 2951 |
|
|
2021
Q1 | $809K | Sell |
15,783
-31,353
| -67% | -$1.89M | ﹤0.01% | 5868 |
|
|
2020
Q4 | $2.92M | Sell |
47,136
-20,927
| -31% | -$1.2M | ﹤0.01% | 2854 |
|
|
2020
Q3 | $3.73M | Buy |
68,063
+44,899
| +194% | +$2.42M | ﹤0.01% | 2193 |
|
|
2020
Q2 | $1.33M | Buy |
23,164
+14,037
| +154% | +$764K | ﹤0.01% | 3654 |
|
|
2020
Q1 | $367K | Buy |
+9,127
| New | +$388K | ﹤0.01% | 3990 |
|
|
2018
Q2 | – | Sell |
-14,429
| Closed | -$196K | – | 5811 |
|
|
2018
Q1 | $196K | Buy |
+14,429
| New | +$149K | ﹤0.01% | 4464 |
|
|
2016
Q3 | – | Sell |
-16,035
| Closed | -$72K | – | 4691 |
|
|
2016
Q2 | $72K | Buy |
+16,035
| New | +$60.2K | ﹤0.01% | 3931 |
|
|
2014
Q2 | – | Sell |
-53,968
| Closed | -$358K | – | 3267 |
|
|
2014
Q1 | $358K | Sell |
53,968
-34,190
| -39% | -$238K | ﹤0.01% | 1840 |
|
|
2013
Q4 | $510K | Buy |
+88,158
| New | +$455K | 0.01% | 1217 |
|
Other funds holding CCXI
Jane Street's CCXI Position: Q4 2022 in Review
Jane Street sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,822 shares — an estimated $404K sold.
Jane Street first reported a position in CCXI in Q4 2013 and held it in 15 quarters. The position peaked at $4.21M in Q2 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Jane Street reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 7,822 ChemoCentryx, Inc. shares in Q4 2022, an estimated $404K.
- Jane Street first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 15 quarters.
- Jane Street's ChemoCentryx, Inc. position peaked at $4.21M in Q2 2021.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.